Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,435 | 183,033 | 190,514 | 183,247 | 36,162 |
| Marketable Securities | 90,573 | N/A | 10,493 | 27,945 | 41,857 |
| Receivables | N/A | 500 | 500 | 500 | N/A |
| TOTAL | $165,178 | $186,430 | $205,196 | $213,929 | $80,034 |
| Non-Current Assets | |||||
| PPE Net | 9,225 | 8,402 | 5,125 | 3,798 | 2,894 |
| Other Non-Current Assets | 25,474 | 26,033 | 2,711 | 2,227 | 227 |
| TOTAL | $34,699 | $34,435 | $7,836 | $6,025 | $3,121 |
| Total Assets | $199,877 | $220,865 | $213,032 | $219,954 | $83,155 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,447 | 3,941 | 2,438 | 3,264 | 2,011 |
| Accounts payable and accrued liabilities | 5,410 | 5,367 | 4,205 | 5,236 | 3,510 |
| Accrued Expenses | 9,834 | 9,950 | 10,926 | 9,638 | 8,376 |
| Other current liabilities | 2,106 | 2,106 | 2,106 | 1,284 | 600 |
| TOTAL | $29,418 | $29,140 | $27,263 | $22,672 | $16,273 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,469 | 10,958 | 12,446 | 11,601 | 12,835 |
| Deferred Revenues | 5,049 | 6,576 | 7,588 | 3,250 | 1,776 |
| Other Non-Current Liabilities | 28,220 | 28,550 | 5,354 | 3,752 | 2,222 |
| TOTAL | $42,933 | $45,888 | $25,300 | $23,353 | $15,057 |
| Total Liabilities | $72,351 | $75,028 | $52,563 | $46,025 | $31,330 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,386 | 65,186 | 65,000 | 64,519 | 53,419 |
| Common Shares | 65 | 65 | 65 | 65 | 53 |
| Retained earnings | -328,634 | -305,156 | -285,396 | -269,369 | -252,587 |
| Other shareholders' equity | 96 | 3 | 1 | -11 | -12 |
| TOTAL | $127,526 | $145,837 | $160,469 | $173,929 | $51,825 |
| Total Liabilities And Equity | $199,877 | $220,865 | $213,032 | $219,954 | $83,155 |